Promising effect of intravenous immunoglobulin therapy for epidermolysis bullosa pruriginosa.

Ertop Doğan Pelin Seçil VuralEzgi Gökpınar IliCeren Damla DurmazAylin O HeperJohn S McGrathRuhi H IlgınAyşe Boyvat

Published in: International journal of dermatology (2020)

In severe cases, unresponsive to other therapies, IVIG may be a preferable therapeutic approach to modulate the inflammatory response in patients with EBP.

Keyphrases

inflammatory response
lipopolysaccharide induced
lps induced
toll like receptor
high dose
early onset
drug induced